Early Administration of Tirofiban in High-risk Patients with Non-ST Elevation Acute Coronary Syndrome Referred for Percutaneous Coronary Intervention

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002699

Enrollment

Unknown

Registered

2012-04-24

Start date

2010-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-ST Elevation Acute Coronary Syndrome

Interventions

Interventional group:early administration of tirofiban at least 12 hour

Control group:administration of tirofiban during PCI operation

Eligibility

Sex/Gender

All

Age

33 Years to 76 Years

Inclusion criteria

Inclusion criteria: 1. Must have a diagnosis of one of NSTEACS and ready to PCI; 2. Aged 18 to 75 years; 3. TIMI Score >=3; 4. Must hospitalized >=1 day and relevant therapy has been applied.

Exclusion criteria

Exclusion criteria: 1. High risk patients need to perform emergency PCI; 2. Pregnant or suspicious pregnant; 3. High risk for bleeding.

Design outcomes

Primary

Measure	Time frame
MACE event;	—

Secondary

Measure	Time frame
Bleeding episode;	—

Contacts

Public ContactHUO Yong

huoyong@263.net.cn+86 010 010-66552370

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026